These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1971563)

  • 21. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Nov; 64(5):477-83. PubMed ID: 9834039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug interaction between simvastatin and cholestyramine in vitro and in vivo.
    Nakai A; Nishikata M; Matsuyama K; Ichikawa M
    Biol Pharm Bull; 1996 Sep; 19(9):1231-3. PubMed ID: 8889048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil.
    Prueksaritanont T; Qiu Y; Mu L; Michel K; Brunner J; Richards KM; Lin JH
    Pharm Res; 2005 Jul; 22(7):1101-9. PubMed ID: 16028010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
    Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
    Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the metabolic inversion of the 6'chiral center of simvastatin.
    Vickers S; Duncan CA
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1508-15. PubMed ID: 1764101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of plasma mevalonate and 7alpha-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation.
    Shoda J; Miyamoto J; Kano M; Ikegami T; Matsuzaki Y; Tanaka N; Osuga T; Miyazaki H
    Hepatology; 1997 Jan; 25(1):18-26. PubMed ID: 8985259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N,N'-bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells.
    Soma MR; Pagliarini P; Butti G; Paoletti R; Paoletti P; Fumagalli R
    Cancer Res; 1992 Aug; 52(16):4348-55. PubMed ID: 1643632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
    Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics and practical applications of simvastatin.
    Mauro VF
    Clin Pharmacokinet; 1993 Mar; 24(3):195-202. PubMed ID: 8343198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors.
    Parker RA; Clark RW; Sit SY; Lanier TL; Grosso RA; Wright JJ
    J Lipid Res; 1990 Jul; 31(7):1271-82. PubMed ID: 2401858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative.
    Slater EE; MacDonald JS
    Drugs; 1988; 36 Suppl 3():72-82. PubMed ID: 3076125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor).
    Horsmans Y; Desager JP; Harvengt C
    Pharmacol Toxicol; 1990 Oct; 67(4):336-9. PubMed ID: 2077527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors.
    Gerson RJ; MacDonald JS; Alberts AW; Chen J; Yudkovitz JB; Greenspan MD; Rubin LF; Bokelman DL
    Exp Eye Res; 1990 Jan; 50(1):65-78. PubMed ID: 2307197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form.
    McClelland GA; Stubbs RJ; Fix JA; Pogany SA; Zentner GM
    Pharm Res; 1991 Jul; 8(7):873-6. PubMed ID: 1924137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
    Nagata Y; Hidaka Y; Ishida F; Kamei T
    Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.
    Bocan TM; Ferguson E; McNally W; Uhlendorf PD; Bak Mueller S; Dehart P; Sliskovic DR; Roth BD; Krause BR; Newton RS
    Biochim Biophys Acta; 1992 Jan; 1123(2):133-44. PubMed ID: 1739744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high-performance liquid chromatography with UV detection.
    Carlucci G; Mazzeo P; Biordi L; Bologna M
    J Pharm Biomed Anal; 1992 Sep; 10(9):693-7. PubMed ID: 1286134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid.
    Subramanian R; Fang X; Prueksaritanont T
    Drug Metab Dispos; 2002 Mar; 30(3):225-30. PubMed ID: 11854137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.